“drugs” Archives

Entry Author Date Location
BDSI Cancer Pain Drug Approved Again, Search Continues for New Partner 08/13/15 Raleigh Durham
Aimmune Prices Upsized $160M IPO, Climbs Higher in Debut 08/06/15 San Francisco
Roundup: New Money for FlexGen, Neos, MacroFab, Castle & Other News 08/03/15 Texas
Shire Snaps up New York’s Foresight Bio in $300M Pink Eye Deal 08/03/15 New York
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Synergy Hits Mark on Second Trial, Eyes Approval For Constipation Drug 07/30/15 New York
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
University of Houston’s Rathindra Bose Dies at 63 07/22/15 Texas
With New Alzheimer’s Data, Biogen Refines Plans For Big Trial 07/22/15 Boston
MoneyTree Shows Drop in San Diego VC Funding, and Top 15 Deals 07/17/15 San Diego
Judge Rejects Court Order Requested in Fight Over Alzheimer’s Study 07/16/15 San Diego
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
Neos Therapeutics, Maker of ADHD Drug Delivery System, Files IPO 07/13/15 Texas
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
Aimmune May Seek Up To $115M in IPO for Allergy Therapy Drug 07/07/15 San Francisco
Deeper Issues Underlie UC San Diego Lawsuit Over Raid by USC 07/06/15 San Diego
Biopharmaceutical Haiku, Round Two 07/06/15 Seattle
AstraZeneca Working with Eolas Therapeutics on Anti-Addiction Drug 06/30/15 San Diego
Texas Roundup: SXSW, SparkCognition, TMCx, & Austin’s Biotech Scene 06/30/15 Texas
San Diego’s Ambrx Names New CEO, CSO 06/25/15 San Diego
Accera Pivots From Medical Foods to Potential Drug for Alzheimer’s 06/23/15 Boulder/Denver
Houston Dares to Challenge the Bicoastal Model of Biotech Growth 06/23/15 Texas
The Extraordinary Vision of Larry Bock 06/23/15 San Diego
Epizyme Shares Climb on New Data for Cancer Drug 06/22/15 Boston
Cystic Fibrosis Drug Maker Nivalis Therapeutics Has $77M IPO 06/17/15 Boulder/Denver
Austin Biotech Aeglea BioTherapeutics Files for IPO for Cancer Therapies 06/16/15 Texas
Aerie Surges As FDA Agrees to New Goals for Glaucoma Trial 06/16/15 New York
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout 06/11/15 Detroit Ann Arbor
Failed Trial for Hepatitis B Drug Leads to Layoffs at GlobeImmune 06/10/15 Boulder/Denver
Page 3 of 85 « previous page · next page »